{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:05:48Z","timestamp":1781309148296,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese Scholarship Council student fellowship grant"},{"name":"National Institutes of Health (NIH) Grant","award":["HL139793"],"award-info":[{"award-number":["HL139793"]}]},{"DOI":"10.13039\/100000928","name":"Robert A. Welch Foundation","doi-asserted-by":"crossref","award":["I-0011"],"award-info":[{"award-number":["I-0011"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Grants","award":["NS060703"],"award-info":[{"award-number":["NS060703"]}]},{"name":"NIH Grants","award":["NS067525"],"award-info":[{"award-number":["NS067525"]}]},{"name":"Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.prostaglandins.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T15:24:13Z","timestamp":1530977053000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The contribution of TRPV1 channel to 20-HETE\u2014Aggravated ischemic neuronal injury"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-2510","authenticated-orcid":false,"given":"Xiaofan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-2514","authenticated-orcid":false,"given":"Nagat","family":"El Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-7845","authenticated-orcid":false,"given":"John R.","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailu","family":"Munnuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.07.001_bib0010","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.116.015146","article-title":"20-hydroxyeicosatetraenoic acid as a predictor of neurological deterioration in acute minor ischemic stroke","volume":"47","author":"Yi","year":"2016","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/STROKEAHA.110.605816","article-title":"Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Crago","year":"2011","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.07.001_bib0020","doi-asserted-by":"crossref","first-page":"R1412","DOI":"10.1152\/ajpregu.00003.2009","article-title":"Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion","volume":"296","author":"Cao","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2018.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/jcbfm.2012.68","article-title":"Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor","volume":"32","author":"Kawasaki","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.07.001_bib0030","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1476-5381.2010.00973.x","article-title":"The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice","volume":"161","author":"Marumo","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.07.001_bib0035","doi-asserted-by":"crossref","first-page":"H1285","DOI":"10.1152\/ajpheart.00340.2011","article-title":"Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures","volume":"302","author":"Renic","year":"2012","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.07.001_bib0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neures.2007.08.018","article-title":"Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats","volume":"59","author":"Tanaka","year":"2007","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1471-4159.2012.07666.x","article-title":"Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor","volume":"121","author":"Yang","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prostaglandins.2018.07.001_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostagland. Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.07.001_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/jcbfm.2008.156","article-title":"Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion","volume":"29","author":"Renic","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10571-017-0462-8","article-title":"Upregulation of 20-HETE synthetic cytochrome P450 isoforms by oxygen-glucose deprivation in cortical neurons","volume":"37","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20061328","article-title":"Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation","volume":"403","author":"Muller","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.prostaglandins.2018.07.001_bib0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.neuro.24.1.487","article-title":"The vanilloid receptor: a molecular gateway to the pain pathway","volume":"24","author":"Caterina","year":"2001","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.prostaglandins.2018.07.001_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-5-31","article-title":"Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons","volume":"5","author":"Ma","year":"2009","journal-title":"Mol. Pain"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.07.001_bib0080","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1523\/JNEUROSCI.4166-04.2005","article-title":"Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro","volume":"25","author":"Kim","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5607\/en.2013.22.1.51","article-title":"TRPV1 activation in primary cortical neurons induces calcium-dependent programmed cell death","volume":"22","author":"Song","year":"2013","journal-title":"Exp. Neurobiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.07.001_bib0090","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bbrc.2008.10.152","article-title":"TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons","volume":"377","author":"Shirakawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.prostaglandins.2018.07.001_bib0095","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1074\/jbc.M111.334896","article-title":"20-hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel","volume":"287","author":"Wen","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.07.001_bib0100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.111.00942","article-title":"Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase a","volume":"62","author":"Bubb","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.07.001_bib0105","doi-asserted-by":"crossref","first-page":"L460","DOI":"10.1152\/ajplung.00252.2004","article-title":"Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle","volume":"288","author":"Rousseau","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.07.001_bib0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410090206","article-title":"The influence of immaturity on hypoxic-ischemic brain damage in the rat","volume":"9","author":"Rice","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.prostaglandins.2018.07.001_bib0115","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1038\/ncomms15292","article-title":"TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice","volume":"8","author":"Marrone","year":"2017","journal-title":"Nat. Commun."},{"issue":"5 Pt 2","key":"10.1016\/j.prostaglandins.2018.07.001_bib0120","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"277","author":"Alonso-Galicia","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2009.10.019","article-title":"Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase\/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons","volume":"221","author":"Yang","year":"2010","journal-title":"Exp. Neurol."},{"issue":"13","key":"10.1016\/j.prostaglandins.2018.07.001_bib0130","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1523\/JNEUROSCI.6451-10.2011","article-title":"Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells","volume":"31","author":"Cavanaugh","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prostaglandins.2018.07.001_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.niox.2013.05.001","article-title":"Contribution of iNOS\/sGC\/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock","volume":"33","author":"Tunctan","year":"2013","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.07.001_bib0140","doi-asserted-by":"crossref","first-page":"L902","DOI":"10.1152\/ajplung.00278.2007","article-title":"20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells","volume":"294","author":"Medhora","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.07.001_bib0145","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1152\/ajpregu.00329.2013","article-title":"Pharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion","volume":"306","author":"Cao","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.07.001_bib0150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/jcbfm.2012.36","article-title":"Ischemic neuroprotection by TRPV1 receptor-induced hypothermia","volume":"32","author":"Muzzi","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.07.001_bib0155","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1523\/JNEUROSCI.4671-10.2011","article-title":"Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis","volume":"31","author":"Garami","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.07.001_bib0160","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1460-9568.2004.03221.x","article-title":"Daily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice","volume":"19","author":"Szelenyi","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.07.001_bib0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2004.12.007","article-title":"Attenuated fever response in mice lacking TRPV1","volume":"378","author":"Iida","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.07.001_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.112.191932","volume":"342","author":"Nash","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.07.001_bib0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.110.175570","article-title":"Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect","volume":"336","author":"Watabiki","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.07.001_bib0180","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318300741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318300741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T18:28:29Z","timestamp":1560450509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882318300741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":36,"alternative-id":["S1098882318300741"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.07.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of TRPV1 channel to 20-HETE\u2014Aggravated ischemic neuronal injury","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}